Protagonist, Ironwood expand peptide R&D deal

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

Luminex restructures, shuts down Australian office

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Luminex entered a restructuring plan focused on its assay and related products (ARP) segment's newborn screening group and has decided to shut down its Brisbane office in Austral...Read more

Lonza produces Bionomics' stem cell cancer drug

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies. Lonza will manufacture BNC1...Read more

Irish firm's track-&-trace system to curb fake drugs

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at eliminating the use of counterfeit drugs. Leading the battle against...Read more

iSonea launches asthma monitoring device in Australia

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Sep, 2013

Singapore: Australian medical technology company, iSonea, launched AirSonea wheeze monitoring device, in the Australian market. The device is intended for people, who are diagnosed with ast...Read more

Will the next blockbuster emerge from Asia?

Australia |  Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012

Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies in Asia? Two years...Read more

One compound to kill all known malarial strains

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

Singapore: A recently discovered compound from the aminopyridine class could be a potential single-dose cure for all strains of malaria. The compound might also be able to block transmissio...Read more

Bionomics seeks $4.2 mn R&D tax incentive

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

Singapore: Bionomics has lodged its FY 2012 tax return and registered with AusIndustry (on behalf of Innovation Australia) for the Australian R&D tax incentive. Bionomics anticipates t...Read more

Indian, Australian science academies sign MoU

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

Singapore: The Australian Academy of Science (AAS) and Indian National Academy of Science (INAS) renewed their commitment to work more closely together. Professor Suzanne Cory, president,...Read more

Bionomics acquires US cancer firm

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition of a private biotechnology company Eclipse Therapeutics. The company a...Read more

Hettich, LBT form landmark bio-software JV

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Medical technology company, LBT Innovations, signed a landmark agreement with Switzerland-based laboratory instrumentation company Hettich, to establish a joint venture to drive ...Read more

Spinifex phase II postherpetic neuralgia trial is a success

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, revealed positive headline results from the phase II clinical trial of its lead product, EMA401, in posth...Read more

Australia is 3rd largest in terms of total company revenues

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. It leveraged ...Read more

Real-Time Location Systems are a big hit in Asia

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

Singapore: Rising costs are compelling hospitals in South East Asia, Australia and New Zealand (ANZ) to streamline their operations, which, in turn, is opening up several opportunities for ...Read more

Genetic Technologies gets US patent update

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

Singapore: The US patent and trademark office (US PTO) has issued an action reaffirming the validity of certain claims contained in the Genetic Technologies' US Patent No. 5,612,179 (the '1...Read more

Japanese I'rom acquires 18% in Australian IDT

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

Nancy Millis - 'First Lady' of Australian biotech - passes away

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

Singapore: Eminent Australian microbiologist Emeritus Professor Nancy Millis AC, who served as the chancellor of La Trobe University for 14 years, passed away on September 29, 2012. Also kn...Read more

Prima recruits patients for cancer vaccine trial

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more